Related Experiment Videos
Quantitative estimation of clofazimine in tissue
Leprosy in India
|October 1, 1976
Summary
Clofazimine accumulates in organs rich in macrophages, like the reticulo-endothelial system. This leprosy drug shows slow tissue elimination, with skin levels correlating to granuloma size even years after discontinuation.
Area of Science:
- Pharmacology
- Histopathology
- Dermatology
Background:
- Clofazimine is a key drug in treating leprosy and other mycobacterial infections.
- Understanding its tissue distribution and elimination is crucial for optimizing treatment and managing side effects.
Purpose of the Study:
- To investigate the tissue accumulation and elimination patterns of clofazimine.
- To correlate clofazimine skin levels with granuloma size and duration of drug therapy.
Main Methods:
- Histological examination of organs from autopsy.
- Chemical estimation of clofazimine levels in various tissues, particularly skin.
- Comparison of skin clofazimine levels in patients with different treatment durations.
Main Results:
- Clofazimine accumulates in organs of the reticulo-endothelial system and macrophages.
- Skin clofazimine levels directly correlate with the size of granulomas.
- Traces of clofazimine persist in skin tissue 1-2 years after drug cessation, indicating slow elimination.
Conclusions:
- Clofazimine exhibits significant accumulation in macrophage-rich tissues.
- The drug's slow elimination from skin has implications for long-term treatment monitoring and potential toxicity.
- Findings support understanding clofazimine pharmacokinetics in managing mycobacterial diseases.